Most recently, Imbria Pharmaceuticals raised $66.7M in its Later Stage VC (Series B) (Dec 2025).
- ·Watch Imbria Pharmaceuticals: the Monday email on marks, rounds and moves
Imbria Pharmaceuticals round by round
2 roundsHow much has Imbria Pharmaceuticals raised?
Imbria Pharmaceuticals has raised $152 million in total; 2 of its rounds are on record. The largest on record was a $66.7 million Series B in Dec 2025.
Imbria Pharmaceuticals has filed 2 Form Ds with the SEC since 2020, most recently in Apr 2025 ($59.2 million sold to 8 investors).
Imbria Pharmaceuticals investors
9 investors are on record for Imbria Pharmaceuticals, including RA Capital Management, Catalio Capital Management, SV Health Investors and Deep Track Capital. The Series B in Dec 2025 drew 6 investors.
9 investors have backed Imbria Pharmaceuticals — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Imbria Pharmaceuticals
- How much has Imbria Pharmaceuticals raised?
- Imbria Pharmaceuticals has raised $151.9M in total across 2 recorded funding rounds.
- When was Imbria Pharmaceuticals's last funding round?
- Imbria Pharmaceuticals's most recent recorded round was Later Stage VC (Series B) in Dec 2025, raising $66.7M.